Bacteriophage-antibiotic synergism to control planktonic and biofilm producing clinical isolates of Pseudomonas aeruginosa

详细信息    查看全文

• 作者：Amina Amal Mahmoud Nouraldin¹ ; ^{aminan@hotmail.com" class="auth_mail" title="E-mail the corresponding author} ; Manal Mohammad Baddour² ; ^{manal.baddour@alexmed.edu.eg" class="auth_mail" title="E-mail the corresponding author} ; Reem Abdel Hameed Harfoush³ ; ^{rim94alex@yahoo.com" class="auth_mail" title="E-mail the corresponding author} ; Sara AbdelAziz Mohamed Essa ; ^{Sara_aziz05@yahoo.com" class="auth_mail" title="E-mail the corresponding author}
• 关键词：P. aeruginosa ; Bacteriophages ; Antibiotics ; Biofilm ; Planktonic ; Synergism
• 刊名：Alexandria Journal of Medicine
• 出版年：2016
• 出版时间：June 2016
• 年：2016
• 卷：52
• 期：2
• 页码：99-105
• 全文大小：440 K

文摘

Pseudomonas aeruginosa (P. aeruginosa) is a highly resistant opportunistic pathogen and is capable of forming biofilms on medical devices. Bacterial biofilms, which are micro-colonies encased in extracellular polysaccharide material are so difficult to be treated by conventional antibiotics. During the last decade, P. aeruginosa phages have been extensively examined as an alternative to antimicrobial agents. The aim of the study was to assess bacteriophage-antibiotic combination on planktonic and biofilm states of P. aeruginosa isolates.

Materials

In this study, we isolated 6 lytic phages, from hospital effluents, they were tested against 50 P. aeruginosa strains, isolated from different clinical specimens delivered to the Diagnostic Microbiology Laboratories, Faculty of Medicine, Alexandria University.

Results

Out of the 50 isolates, 15 were susceptible to these phages. So the biofilm forming capacity of these 15 isolates was investigated. The results showed that 14 isolates (93.33%) produced detectable biofilm. The minimum inhibitory concentration (MIC) and minimum biofilm eradication concentration (MBEC) assays were used to evaluate the antibiotic sensitivity patterns of these P. aeruginosa isolates in their planktonic and biofilm phases to amikacin and meropenem. Also, the effects of phage on the planktonic and biofilm states of isolates at different multiplicities of infections (MOI) were tested. On the planktonic state, the amikacin-phage combination showed synergistic effect (P = 0.001), and the meropenem-phage combination showed synergistic effect (P = 0.003). On the biofilm state, the amikacin-phage combination showed biofilm eradication in 50% of the isolates (P = 0.003). On the other hand, the meropenem-phage combination showed biofilm eradication in 14.3% of the strains.

Conclusion

The combination of phage and antibiotics could have potentially more benefits on P. aeruginosa planktonic and biofilm states than just using phages or antibiotics alone.